Toho Zinc Co (5707) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
27 Feb, 2026Strategic direction and revitalization plan
Executing a business revitalization plan focused on exiting mineral resources, reorganizing zinc smelting, and boosting lead and silver smelting profitability.
Investments target enhanced competitiveness, leveraging high silver prices and improving business resilience.
Aims to transform the business structure around smelting and refining for long-term value.
Investment breakdown and objectives
Total planned investment of 6,056 million yen across three main areas: plant digital transformation (DX), expanding recoverable elements, and process streamlining for waste batteries and crude lead.
Plant DX investment (1,756 million yen) will modernize core plants with real-time data systems to improve productivity and stability from April 2026 to March 2029.
3,050 million yen allocated to enhance recovery and purity of precious/rare metals and process complex ores, with a focus on hydrometallurgical R&D and equipment upgrades.
1,250 million yen to strengthen organizational structure and processes for increased recycling and cost reduction, especially for waste batteries and crude lead, from September 2026 to March 2028.
Financing strategy and structure
Plans to raise about 6 billion yen via moving-strike stock acquisition rights (MS warrants), with 3.5 million shares issued (11.2% dilution), exercisable over 24 months from March 2026.
Financing chosen for flexibility, gradual dilution, and ability to suspend exercises to manage share price impact.
Allottee selected for phased funding certainty and capital market expertise; stock lending arrangements in place.
Latest events from Toho Zinc Co
- Profit rose on high silver prices and asset sales, but equity and dividends declined.5707
Q3 202613 Feb 2026 - Q2 saw positive EBITDA, but sharp losses and suspended dividends highlight ongoing challenges.5707
Q2 202613 Nov 2025 - Profitability rebounded in FY2024, but ongoing restructuring and risks to stability persist.5707
Q4 202519 Aug 2025 - Revenue fell 23% and net income turned negative amid restructuring and a cautious outlook.5707
Q1 202619 Aug 2025